News

Article

bit.bio cell therapy pipeline featured in Endpoints News

Endpoints News did an exclusive interview with bit.bio's CEO after the cell therapy pipeline announcement with an initial focus on the liver.

17.11.2023

Published by Endpoints News

Endpoints News did an exclusive interview with bit.bio's CEO after the cell therapy pipeline announcement with an initial focus on the liver.

Published by Endpoints News

Read now

Article

bit.bio named as one of the WIRED Trailblazers in Cambridge

WIRED have named 16 Trailblazer companies in Cambridge that are pushing boundaries and scaling up - including bit.bio.

16.10.2023

Published by Wired

Read now

Article

Five things you need to succeed as a leader - Authority Magazine Q&A

Authority Magazine interviewed bit.bio's SVP of tech ops and manufacturing Kathryn Golden to discover her path to leadership and w...

16.10.2023

Published by Authority Magazine

Read now

Article

Navigating the future of cell therapies with exec Kathryn Corzo

Our President and COO Kathryn Corzo talks with editor Brian Buntz from Drug Discovery & Development.

30.08.2023

Published by Drug Discovery & Development

Read now

Article

Synthetic biology: impacting drug discovery

Our CEO Mark Kotter talks to Drug Discovery World about different approaches to synthetic biology and its applications in drug dis...

07.07.2023

Published by DDW journal online

Read now

Article

proto.life feature on industrial manufacture of human cells

This in depth feature covers bit.bio's breakthrough reprogramming approach and ability to manufacture human cells at industrial sc...

28.06.2023

Published by proto.life

Read now

Article

The power of automation featured in Scientist Live

Kathryn Golden, SVP Technical Operations & Cell Manufacturing, discusses how our opti-ox technology lends itself to scale through ...

20.06.2023

Published by Scientist Live

Read now

Article

iNews feature on consistency data presented at ISSCR by bit.bio

The piece covers bit.bio's breakthrough in industrialising the consistent manufacture of human cells and how this will transform h...

14.06.2023

Published by iNews

Read now

Article

bit.bio featured in Forbes

The piece covers the launch of bit.bio's Custom ioDisease Model Cells at the SynBioBeta conference.

06.06.2023

Published by Forbes

Read now

Related pages